PE20001116A1 - Derivados del tiazol - Google Patents
Derivados del tiazolInfo
- Publication number
- PE20001116A1 PE20001116A1 PE1999001048A PE00104899A PE20001116A1 PE 20001116 A1 PE20001116 A1 PE 20001116A1 PE 1999001048 A PE1999001048 A PE 1999001048A PE 00104899 A PE00104899 A PE 00104899A PE 20001116 A1 PE20001116 A1 PE 20001116A1
- Authority
- PE
- Peru
- Prior art keywords
- cycloalkyl
- alkyl
- heteroaryl
- thazol
- ureide
- Prior art date
Links
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical class C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 abstract 1
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 101001043818 Mus musculus Interleukin-31 receptor subunit alpha Proteins 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 102100035140 Vitronectin Human genes 0.000 abstract 1
- 108010031318 Vitronectin Proteins 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical class C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A DERIVADOS DE TIAZOL DE FORMULA I DONDE, R1 ES R4-(CH2)b-NR5CONR6, (R7HN-)(R8HN-)C=N-, (R7HN-)(R8HN=)C-NH-; R2 ES [-CONR9]c(ARILENO)d[CH2]eA[CH2]fCOOH; R3 ES H, ALQUILO, CICLOALQUILO, ARILO, ENTRE OTROS; R4 ES H, ALQUILO, CICLOALQUILO, ARILO, HETEROARILO; R5 Y R6 SON H, ALQUILO, CICLOALQUILO, HETEROARILO; R7 Y R8 SON H, ALQUILO, CICLOALQUILO, HETEROARILO O JUNTO CON N FORMAN UN HETEROCICLICO DE 5 A 8 MIEMBROS CON SUSTITUYENTES ALQUILO; R9 ES H, ALQUILO, CICLOALQUILO; R10 ES H, ARILO, ARALQUILO, HETEROARILO, ENTRE OTROS; A ES O, S, C=C, NR10; a ES 0-2, b ES 0-4, c Y d SON 0-1, e ES 0-5. c Y d NO SON CERO A LA VEZ; e ES DIFERENTE DE CERO CUANDO d ES CERO. SON COMPUESTOS PREFERIDOS (4-{[2-(3-BENCIL-UREIDO)-TIAZOL-4-CARBONIL]-AMINO}-FENOXI)-ACETATO DE ETILO; ACIDO [4-[[2-(3-BENCIL-UREIDO)-TIAZOL-4-CARBONIL]-AMINO-FENOXI)-ACETICO; (4-{[2-(3-BENCIL-UREIDO)-TIAZOL-4-CARBONIL]-AMINO}-2-METOXI-FENOXI)-ACETATO DE ETILO; ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION Y A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE ADEMAS ANTICOAGULANTES, FIBRINOLITICOS. LOS COMPUESTOS DE FORMULA I INHIBEN LA UNION DE LAS PROTEINAS ADHESIVAS COMO FIBRINOGENO, VITRONECTINA A LA SUPERFICIE CELULAR POR LO QUE PUEDEN SER UTILES EN EL TRATAMIENTO DE NEOPLASMAS, METASTASIS DE TUMORES, CRECIMIENTO TUMORAL, OSTEOPOROSIS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98119985 | 1998-10-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001116A1 true PE20001116A1 (es) | 2000-10-27 |
Family
ID=8232838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999001048A PE20001116A1 (es) | 1998-10-22 | 1999-10-18 | Derivados del tiazol |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6297266B1 (es) |
| EP (1) | EP1123283B1 (es) |
| JP (1) | JP3530137B2 (es) |
| KR (1) | KR100469219B1 (es) |
| CN (1) | CN1211375C (es) |
| AR (1) | AR023058A1 (es) |
| AT (1) | ATE266012T1 (es) |
| AU (1) | AU760219B2 (es) |
| BR (1) | BR9914666A (es) |
| CA (1) | CA2347741C (es) |
| CO (1) | CO5150186A1 (es) |
| CZ (1) | CZ20011395A3 (es) |
| DE (1) | DE69917058T2 (es) |
| DK (1) | DK1123283T3 (es) |
| ES (1) | ES2221482T3 (es) |
| HK (1) | HK1047281A1 (es) |
| HR (1) | HRP20010275A2 (es) |
| HU (1) | HUP0104202A3 (es) |
| ID (1) | ID28356A (es) |
| IL (1) | IL142090A0 (es) |
| MA (1) | MA26756A1 (es) |
| NO (1) | NO20011908L (es) |
| NZ (1) | NZ510676A (es) |
| PE (1) | PE20001116A1 (es) |
| PL (1) | PL347427A1 (es) |
| PT (1) | PT1123283E (es) |
| RU (1) | RU2214404C2 (es) |
| TR (1) | TR200101115T2 (es) |
| WO (1) | WO2000024724A1 (es) |
| YU (1) | YU29201A (es) |
| ZA (1) | ZA200102653B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| EP2308833A3 (en) | 1999-04-15 | 2011-09-28 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| ES2287096T3 (es) * | 2000-01-19 | 2007-12-16 | Synvista Therapeutics, Inc. | Compuestos de tiazol, imidazol y oxazol y tratamientos de trastornos asociados con el envejecimiento de las proteinas. |
| US6716995B2 (en) | 2000-08-17 | 2004-04-06 | Lumera Corporation | Design and synthesis of advanced NLO materials for electro-optic applications |
| ES2257461T3 (es) | 2000-12-21 | 2006-08-01 | Bristol-Myers Squibb Company | Inhibidores de tiazolilo de tirosina quinasas de la familia tec. |
| JP2008513386A (ja) * | 2004-09-20 | 2008-05-01 | ４エスシー アーゲー | 新規な複素環式ＮＦ−κＢ阻害剤 |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| WO2010012793A1 (en) * | 2008-08-01 | 2010-02-04 | Bayer Cropscience Sa | Fungicide aminothiazole derivatives |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL95548A0 (en) * | 1989-09-15 | 1991-06-30 | Fujisawa Pharmaceutical Co | Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same |
| US5273982A (en) | 1990-03-09 | 1993-12-28 | Hoffmann-La Roche Inc. | Acetic acid derivatives |
| CA2037153A1 (en) * | 1990-03-09 | 1991-09-10 | Leo Alig | Acetic acid derivatives |
| US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| JPH0987237A (ja) * | 1995-09-21 | 1997-03-31 | Kyowa Hakko Kogyo Co Ltd | 芳香族誘導体 |
| DE69716900T2 (de) | 1996-04-10 | 2003-07-03 | Merck & Co., Inc. | Alpha v Beta 3 ANTAGONISTEN |
| SK176898A3 (en) | 1996-06-28 | 1999-05-07 | Merck Patent Gmbh | Phenylalamine derivatives as integrin inhibitors |
| SI0928793T1 (en) * | 1998-01-02 | 2002-10-31 | F. Hoffmann-La Roche Ag | Thiazole derivatives |
| EP0928790B1 (en) * | 1998-01-02 | 2003-03-05 | F. Hoffmann-La Roche Ag | Thiazole derivatives |
| US6001855A (en) | 1998-01-02 | 1999-12-14 | Hoffman-La Roche Inc. | Thiazole derivatives |
| US6100282A (en) | 1998-01-02 | 2000-08-08 | Hoffman-La Roche Inc. | Thiazole derivatives |
-
1999
- 1999-10-15 PT PT99970988T patent/PT1123283E/pt unknown
- 1999-10-15 CA CA002347741A patent/CA2347741C/en not_active Expired - Fee Related
- 1999-10-15 HR HR20010275A patent/HRP20010275A2/hr not_active Application Discontinuation
- 1999-10-15 HK HK02108922.4A patent/HK1047281A1/zh unknown
- 1999-10-15 AT AT99970988T patent/ATE266012T1/de not_active IP Right Cessation
- 1999-10-15 BR BR9914666-5A patent/BR9914666A/pt not_active IP Right Cessation
- 1999-10-15 NZ NZ510676A patent/NZ510676A/xx unknown
- 1999-10-15 RU RU2001113285/04A patent/RU2214404C2/ru not_active IP Right Cessation
- 1999-10-15 TR TR2001/01115T patent/TR200101115T2/xx unknown
- 1999-10-15 ES ES99970988T patent/ES2221482T3/es not_active Expired - Lifetime
- 1999-10-15 WO PCT/EP1999/007824 patent/WO2000024724A1/en not_active Ceased
- 1999-10-15 KR KR10-2001-7004899A patent/KR100469219B1/ko not_active Expired - Fee Related
- 1999-10-15 PL PL99347427A patent/PL347427A1/xx not_active Application Discontinuation
- 1999-10-15 HU HU0104202A patent/HUP0104202A3/hu unknown
- 1999-10-15 DE DE69917058T patent/DE69917058T2/de not_active Expired - Fee Related
- 1999-10-15 DK DK99970988T patent/DK1123283T3/da active
- 1999-10-15 JP JP2000578294A patent/JP3530137B2/ja not_active Expired - Fee Related
- 1999-10-15 CZ CZ20011395A patent/CZ20011395A3/cs unknown
- 1999-10-15 AU AU11519/00A patent/AU760219B2/en not_active Ceased
- 1999-10-15 CN CNB998124265A patent/CN1211375C/zh not_active Expired - Fee Related
- 1999-10-15 YU YU29201A patent/YU29201A/sh unknown
- 1999-10-15 IL IL14209099A patent/IL142090A0/xx unknown
- 1999-10-15 EP EP99970988A patent/EP1123283B1/en not_active Expired - Lifetime
- 1999-10-15 ID IDW20010863A patent/ID28356A/id unknown
- 1999-10-18 PE PE1999001048A patent/PE20001116A1/es not_active Application Discontinuation
- 1999-10-19 US US09/420,387 patent/US6297266B1/en not_active Expired - Fee Related
- 1999-10-20 AR ARP990105306A patent/AR023058A1/es not_active Application Discontinuation
- 1999-10-20 CO CO99066263A patent/CO5150186A1/es unknown
-
2001
- 2001-03-30 ZA ZA200102653A patent/ZA200102653B/en unknown
- 2001-04-18 NO NO20011908A patent/NO20011908L/no not_active Application Discontinuation
- 2001-04-20 MA MA26171A patent/MA26756A1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE390404T1 (de) | Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta | |
| KR940000447A (ko) | 티아졸의 분지쇄 알킬아미노유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물 | |
| SE8303208L (sv) | Heterocykliska foreningar | |
| PE20040649A1 (es) | Procedimiento para la preparacion de benzoilureas heterociclicamente sustituidas | |
| PE20050018A1 (es) | Compuesto pentaciclico heteroaromatico como inhibidor de la proteina tirosina fosfatasa 1b (ptb1b) | |
| DK317679A (da) | N-substituerede heterocycliske forbindelser femgangsmaade til deres fremstilling samt deres anvendelse | |
| PE20000061A1 (es) | Derivados de tiazol | |
| AR012102A1 (es) | Derivados de 2-(iminometil)amino-fenilo, su preparacion, uso de los mismos para la fabricacion de medicamentos y composiciones farmaceuticas que los contienen. | |
| ATE46157T1 (de) | Benzo(b>thiophen und benzo(b>furancarboxamidderivate, ihre verfahren zur herstellung und sie enthaltende arzneimittel. | |
| PE20001116A1 (es) | Derivados del tiazol | |
| AT384424B (de) | Verfahren zur herstellung von neuen 3-hydroxy-2-oxo-pyrrolidinderivaten und ihren salzen | |
| ES8306753A1 (es) | "procedimiento para la preparacion de nuevos derivados de azepina". | |
| AR018632A1 (es) | Compuestos derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene, proceso para su preparacion. | |
| PT74788B (de) | Verfahren zur herstellung von neuen benzodioxolderivaten | |
| MY101864A (en) | Barbituric acid derivatives | |
| DE3876536D1 (de) | Oxadiazol-pyrimidinone, ihre herstellung und ihre kosmetische und dermopharmazeutische verwendung. | |
| DE60104986D1 (de) | Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis | |
| DK0615971T3 (da) | 5-(Piperazinylalkyl)-1,5-benzothiazepinoner, der kan anvendes som calciumantagonister | |
| BR9801448B1 (pt) | compostos heterocÍclicos, processo para sua preparaÇço e composiÇÕes farmacÊuticas contendo os mesmos. | |
| ZA865255B (en) | Arylethanol-hydroxylamines,process for their preparation and their use for promotion of production | |
| ATE39354T1 (de) | Monosilylierte aminophenylethylamin-derivate, verfahren zu ihrer herstellung und ihre verwendung zur wachstumsfoerderung. | |
| ES8800220A1 (es) | Procedimiento para la produccion de 8-alfa-acilamino-ergolinas. | |
| DE3775921D1 (de) | Verfahren zur herstellung von ethanderivaten. | |
| PE20000116A1 (es) | Derivados de tiazol | |
| PT85873A (de) | Verfahren zur herstellung von aralkyl-4h-1,2,4-triazolderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |